Werewolf Therapeutics Inc

The current institutional shareholding score of Werewolf Therapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 43.59%, representing a quarter-over-quarter increase of 0.70%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.06% of shares outstanding, with 0.21% decrease in holdings.